Nutra Pharma Corporation

Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases. The company carries out basic drug discovery research and clinical development, and also seeks strategic licensing partnerships to reduce the risks associated with the drug development process. Currently, Nutra Pharma offers several drug products for sale for the treatment of pain: Nyloxin, the first over-the-counter (OTC) pain reliever clinically proven to treat moderate to severe (Stage 2) chronic pain, and Nyloxin Extra Strength, the only non-narcotic and non-addictive treatment...

Pain,multiple sclerosis,hiv/aids,rheumatoid arthritis,and chronic pain

Nutra pharma corporation operates in the Biotechnology research industry.

Nutra pharma corporation's revenue is < 1m

Nutra pharma corporation has 11 - 50 employees.